Prescriptions made by Daniel Jeremy Cosgrove

Data for 2018

1,319

Medicare Part D Prescriptions Filled, Including Refills

Rank: 384 out of 1,129 providers in this state and specialty

$167.4K

Total Retail Price of All Prescriptions

Rank: 349 out of 1,129 providers in this state and specialty

292

Patients Receiving at Least One Drug in Part D

Rank: 311 out of 1,129 providers in this state and specialty

-

Average Risk Score

Not enough data available

76

Average Age of Patients

Average age of patients for providers in this state and specialty is 74

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Urology in California and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 TAMSULOSIN HCL3230
of 9780
2940 prescriptions
Less than 1% of all prescriptions
2940750 patients
26% of all patients
750 patients
26% of all patients
2 ALFUZOSIN HCL ER
(ALFUZOSIN HCL)
330
of 4040
2090 prescriptions
Less than 1% of all prescriptions
550 patients
19% of all patients
< 11
3 FINASTERIDE3150
of 8980
1580 prescriptions
Less than 1% of all prescriptions
1580350 patients
12% of all patients
350 patients
12% of all patients
4 MYRBETRIQ
(MIRABEGRON)
1750
of 6600
690 prescriptions
Less than 1% of all prescriptions
170 patients
6% of all patients
< 11
5 CIALIS
(TADALAFIL)
180
of 2500
800 prescriptions
Less than 1% of all prescriptions
150 patients
5% of all patients
< 11
6 DUTASTERIDE1240
of 3890
260 prescriptions
Less than 1% of all prescriptions
260< 11< 11
7 RAPAFLO
(SILODOSIN)
670
of 2880
260 prescriptions
Less than 1% of all prescriptions
260< 11< 11
8 VESICARE
(SOLIFENACIN SUCCINATE)
1070
of 4940
340 prescriptions
Less than 1% of all prescriptions
< 11< 11
9 TOVIAZ
(FESOTERODINE FUMARATE)
490
of 2460
270 prescriptions
Less than 1% of all prescriptions
270< 11< 11
10 NITROFURANTOIN
(NITROFURANTOIN MACROCRYSTAL)
660
of 2690
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11A
11 TESTOSTERONE CYPIONATE480
of 1580
160 prescriptions
Less than 1% of all prescriptions
< 11< 11
12 OXYBUTYNIN CHLORIDE ER
(OXYBUTYNIN CHLORIDE)
1980
of 6710
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
13 CIPROFLOXACIN HCL1050
of 8000
990 prescriptions
Less than 1% of all prescriptions
990730 patients
25% of all patients
730 patients
25% of all patients
A
14 TERAZOSIN HCL1520
of 5270
130 prescriptions
Less than 1% of all prescriptions
130< 11< 11
15 TADALAFIL140
of 280
120 prescriptions
Less than 1% of all prescriptions
< 11< 11
16 ANDROGEL
(TESTOSTERONE)
490
of 1770
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
17 METHENAMINE HIPPURATE1010
of 2660
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
18 NITROFURANTOIN MONO-MACRO
(NITROFURANTOIN MONOHYD/M-CRYST)
1090
of 5570
200 prescriptions
Less than 1% of all prescriptions
160 patients
5% of all patients
< 11A
19 CEPHALEXIN1360
of 6060
130 prescriptions
Less than 1% of all prescriptions
130110 patients
4% of all patients
110 patients
4% of all patients
A
20 AMOXICILLIN-CLAVULANATE POTASS
(AMOXICILLIN/POTASSIUM CLAV)
530
of 2200
220 prescriptions
Less than 1% of all prescriptions
170 patients
6% of all patients
< 11A
21 SULFAMETHOXAZOLE-TRIMETHOPRIM
(SULFAMETHOXAZOLE/TRIMETHOPRIM)
1450
of 7580
150 prescriptions
Less than 1% of all prescriptions
150130 patients
4% of all patients
130 patients
4% of all patients
A